pulmonary-hypertension

Documents about pulmonary-hypertension

• Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension#882556ClinicalTrials.gov
• Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography#279609ClinicalTrials.gov
• Automated CT-Based Quantification of Pulmonary Veins Shows Greater Central Venous Dilation in Group 2 Pulmonary Hypertension Compared With Group 1 Pulmonary Arterial Hypertension and Control Subjects#428253PubMed Central
• Clinical, Radiological, Tissue and Biological Phenotyping for the Analysis of the Transition From Physiology to Pathology in Pulmonary Diseases With Pulmonary Hypertension#842099ClinicalTrials.gov
• An Observational Study For Ambrisentan#441999ClinicalTrials.gov
• 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension#7052OpenAlex
• An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension#18726ClinicalTrials.gov
• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)#18766ClinicalTrials.gov
• Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery#67742ClinicalTrials.gov
• Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension#146328ClinicalTrials.gov
• A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2#287407ClinicalTrials.gov
• Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension#366677ClinicalTrials.gov
• Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension#444784ClinicalTrials.gov
• The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.#474846ClinicalTrials.gov
• Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection#803740ClinicalTrials.gov
• An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)#872055ClinicalTrials.gov
• Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension#878224ClinicalTrials.gov
• Right Ventricular Function During Exercise in Highlanders/Lowlanders#905809ClinicalTrials.gov
• An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension#980549ClinicalTrials.gov
• Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension#994157ClinicalTrials.gov
• Endothelial Cell Activation and Total Pulmonary Resistance in PAH#442013ClinicalTrials.gov
• Exercise Hemodynamics in Patients With Pulmonary Fibrosis#850399ClinicalTrials.gov
• Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty#895519ClinicalTrials.gov
• IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn#172436ClinicalTrials.gov
• Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study#195452ClinicalTrials.gov
• Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE#230521ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery#283136ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension#307328ClinicalTrials.gov
• A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension#369930ClinicalTrials.gov
• Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH#411278ClinicalTrials.gov
• GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)#842330ClinicalTrials.gov
• Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)#889262ClinicalTrials.gov
• Observatory: Search for Prognostic Factors of Pulmonary Hypertension Post-capillary in Heart Failure#915742ClinicalTrials.gov
• Melatonin Effects on the Left Ventricular Function in Neonates With Persistent Pulmonary Hypertension#968275ClinicalTrials.gov
• Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®#1007810ClinicalTrials.gov
• Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension#1030809ClinicalTrials.gov
• Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension#1033324ClinicalTrials.gov
• Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH#913438ClinicalTrials.gov
• Safety and Efficacy of Balloon Pulmonary Angioplasty in China#847350ClinicalTrials.gov
• A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)#238218ClinicalTrials.gov
• Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)#882334ClinicalTrials.gov
• Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension#901911ClinicalTrials.gov
• CTEPH DIAGNOSIS Europe - MRI#261399ClinicalTrials.gov
• Cardiometabolic Disease and Pulmonary Hypertension#303697ClinicalTrials.gov
• Training Single Arm#813642ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension#123581ClinicalTrials.gov
• An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)#283150ClinicalTrials.gov
• High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m)#414409ClinicalTrials.gov
• HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION#432770ClinicalTrials.gov
• Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study#432772ClinicalTrials.gov